SJS Investment Consulting’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$44.9K	Buy	341 +137	+67%	+$18.2K	0.01%	433
2025 Q4	$28.9K	Buy	204 +197	+2,814%	+$28.5K	﹤0.01%	525
2025 Q3	$983	Buy	7 +1	+17%	+$135	﹤0.01%	1018
2025 Q2	$755	Sell	6 -1	-14%	-$115	﹤0.01%	964
2025 Q1	$775	Sell	7 -3	-30%	-$380	﹤0.01%	1092
2024 Q4	$1.36K	Buy	10 +4	+67%	+$495	﹤0.01%	888
2024 Q3	$692	Sell	6 -3	-33%	-$411	﹤0.01%	1207
2024 Q2	$1.24K	Buy	9 +5	+125%	+$686	﹤0.01%	946
2024 Q1	$552	Hold	4	–	–	﹤0.01%	1252
2023 Q4	$528	Buy	4 +1	+33%	+$115	﹤0.01%	1237
2023 Q3	$338	Hold	3	–	–	﹤0.01%	1343
2023 Q2	$283	Buy	+3	New	+$293	﹤0.01%	1327
2023 Q1	–	Sell	-3	Closed	-$358	–	1614
2022 Q4	$358	Sell	3 -1	-25%	-$117	﹤0.01%	1304
2022 Q3	$0	Buy	+4	New	+$406	﹤0.01%	1364
2022 Q1	$0	Buy	+2	New	+$169	﹤0.01%	1124